Executive Summary
In August 2026, a critical vulnerability (CVE-2026-18844) was identified in the Pulsetto Vagus Nerve Stimulator, a device widely used for non-invasive wellness applications. The flaw allows unauthenticated commands to be sent over its Bluetooth Low Energy (BLE) interface, enabling attackers to disable safety mechanisms or alter stimulation settings. Pulsetto has not responded to mitigation requests, leaving users exposed to potential exploitation.
This incident underscores the growing security risks associated with IoT medical devices, emphasizing the need for robust security measures and prompt vendor responses to vulnerabilities to protect patient safety and device integrity.
Why This Matters Now
The Pulsetto Vagus Nerve Stimulator's vulnerability highlights the urgent need for enhanced security protocols in medical IoT devices to prevent unauthorized access and ensure patient safety.
Attack Path Analysis
An attacker exploited the Pulsetto Vagus Nerve Stimulator's unprotected Bluetooth Low Energy (BLE) interface to send unauthorized commands, leading to device manipulation and potential patient harm.
Kill Chain Progression
This analysis maps confirmed threat intelligence to the full cloud kill chain to show where defensive gaps would emerge as an attack progresses.
Initial Compromise
Description
The attacker exploited the device's BLE interface, which accepted unauthenticated commands, to gain unauthorized access.
Related CVEs
CVE-2026-18844
CVSS 8.1The firmware of the Pulsetto Vagus Nerve Stimulator accepts several undisclosed commands over its Bluetooth Low Energy (BLE) interface without authentication or encryption, allowing an attacker to disable electrical safety mechanisms or modify stimulation output settings.
Affected Products:
Pulsetto Vagus Nerve Stimulator – all
Exploit Status:
no public exploit
MITRE ATT&CK® Techniques
Unauthorized Message: Command Message
Exfiltration Over Bluetooth
Unauthorized Command Message
Wireless Compromise
Valid Accounts
Potential Compliance Exposure
Mapping incident impact across multiple compliance frameworks.
PCI DSS 4.0 – Ensure all system components and software are protected from known vulnerabilities
Control ID: 6.2
NYDFS 23 NYCRR 500 – Cybersecurity Policy
Control ID: 500.03
DORA – ICT Risk Management Framework
Control ID: Article 5
CISA ZTMM 2.0 – Device Security
Control ID: Pillar 3: Devices
NIS2 Directive – Cybersecurity Risk Management Measures
Control ID: Article 21
HIPAA – Risk Analysis
Control ID: 164.308(a)(1)(ii)(A)
Sector Implications
Industry-specific impact of the vulnerabilities, including operational, regulatory, and cloud security risks.
Health Care / Life Sciences
Vagus nerve stimulator vulnerabilities expose patient safety risks through unauthenticated BLE commands, compromising medical device integrity and HIPAA compliance requirements.
Medical Equipment
IoT medical device hidden functionality allows attackers to disable safety mechanisms via unencrypted Bluetooth, creating critical patient safety and device security concerns.
Computer/Network Security
BLE vulnerability demonstrates critical gaps in IoT device security frameworks, requiring enhanced zero trust segmentation and threat detection capabilities for medical devices.
Biotechnology/Greentech
Medical device cybersecurity failures highlight need for stronger encryption protocols and authentication mechanisms in biotechnology therapeutic device development and deployment processes.
Sources
- Pulsetto Vagus Nerve Stimulatorhttps://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-223-02Verified
Frequently Asked Questions
Cloud Native Security Fabric Mitigations and ControlsCNSF
Based on the attack progression modeled above, these are the defensive controls that would constrain each stage.
Aviatrix Zero Trust CNSF is pertinent to this incident as it would likely limit the attacker's ability to exploit unprotected interfaces and reduce the potential for lateral movement and data exfiltration.
Control: Cloud Native Security Fabric (CNSF)
Mitigation: The attacker's ability to exploit unprotected interfaces would likely be constrained, reducing unauthorized access opportunities.
Control: Zero Trust Segmentation
Mitigation: The attacker's ability to escalate privileges would likely be constrained, reducing unauthorized modification of device settings.
Control: East-West Traffic Security
Mitigation: The attacker's ability to move laterally to other devices would likely be constrained, reducing the spread of the attack.
Control: Multicloud Visibility & Control
Mitigation: The attacker's ability to maintain control over the device would likely be constrained, reducing unauthorized command execution.
Control: Egress Security & Policy Enforcement
Mitigation: The attacker's ability to exfiltrate sensitive data would likely be constrained, reducing unauthorized data transfer.
The attacker's ability to cause harm by altering device settings would likely be constrained, reducing potential patient risk.
Impact at a Glance
Affected Business Functions
- Patient Treatment
- Device Safety Mechanisms
Estimated downtime: N/A
Estimated loss: N/A
n/a
Recommended Actions
Key Takeaways & Next Steps
- • Implement Zero Trust Segmentation to restrict device communication to authorized entities.
- • Enforce Egress Security & Policy Enforcement to monitor and control outbound BLE traffic.
- • Utilize Threat Detection & Anomaly Response to identify and respond to unauthorized BLE commands.
- • Apply Inline IPS (Suricata) to detect and block malicious BLE traffic patterns.
- • Ensure all device communications are encrypted to prevent unauthorized access and data exfiltration.
